Page last updated: 2024-11-05

vinyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Vinyl acetate is a colorless liquid with a sweet odor. It is a flammable and toxic compound. Vinyl acetate is produced by the reaction of acetylene and acetic acid. It is used in the production of polyvinyl acetate (PVA), a polymer used in adhesives, paints, and other products. Vinyl acetate is also used in the production of vinyl chloride, a monomer used in the production of polyvinyl chloride (PVC), a widely used plastic. Vinyl acetate is an important industrial chemical and is studied for its use in a variety of applications.'

Cross-References

ID SourceID
PubMed CID7904
CHEMBL ID1470323
CHEBI ID46916
MeSH IDM0057943

Synonyms (109)

Synonym
vinyl acetate
octan winylu
acetic acid vinyl ester
1-acetoxyethylene
vinyl acetate h.q.
vinyle(acetate de)
wln: 1vo1u1
nsc8404
vyac
ethenyl acetate
vinyl a monomer
zeset t
vinylacetaat
acetate de vinyle
acetic acid ethenyl ester
vinyl ethanoate
vinylacetat
nsc-8404
ethanoic acid, ethenyl ester
ethenyl ethanoate
acetic acid, ethenyl ester
108-05-4
vinile(acetato di)
inchi=1/c4h6o2/c1-3-6-4(2)5/h3h,1h2,2h
VAC ,
NCGC00091098-01
vinylester kyseliny octove [czech]
octan winylu [polish]
einecs 203-545-4
acetate de vinyle [french]
vinylacetat [german]
acetic acid, vinyl ester
hsdb 190
vinile (acetato di) [italian]
acetic acid, ethylene ether
vinyl acetate monomer
vinylacetate
un1301
nsc 8404
vinylacetaat [dutch]
ai3-18437
ccris 1306
vinyle (acetate de) [french]
9003-20-7
vinyl acetate, contains 3-20 ppm hydroquinone as inhibitor, >=99%
vinylazetat
acetoxyethene
essigsaeurevinylester
CHEBI:46916 ,
acetic acid vinyl ester monomer
A0045
FT-0695979
A801803
NCGC00091098-02
vinylester kyseliny octove
vinile (acetato di)
l9mk238n77 ,
unii-l9mk238n77
vinyl acetate, inhibited
ec 203-545-4
vinyle (acetate de)
vinyl acetate, inhibited [un1301] [flammable liquid]
C19309
dtxcid201431
cas-108-05-4
NCGC00258371-01
tox21_200817
dtxsid3021431 ,
AKOS009120081
acetoxyethylene
vyar
FT-0621762
STL264216
CHEMBL1470323
vinyl acetate [inci]
vinyl acetate [iarc]
copovidone impurity c [ep impurity]
vinyl acetate [hsdb]
vinyl acetate [mi]
vinyl acetate contains 3-20 ppm hydroquinone as inhibitor
un 1301 (salt/mix)
unocal 76 res s-55
everflex 81l
plyamul 40305-00
vinyl ester of acetic acid
vinnapas a 50
unocal 76 res 6206
ch3co2ch=ch2
F8880-1173
J-002050
mfcd00008713
vinyl acetate, analytical standard
vinyl acetate, cp
vinyl acetate monomer (stabilized with hq)
vinyl acetate, european pharmacopoeia (ep) reference standard
vinyl acetate 2000 microg/ml in methanol
vinyle
vinile
vinylacetat(german)
ethenyl acetate, 9ci
Q377339
BBL036266
EN300-27348
vinyl acetate, stabilized
rp 251 (ester)
rp 251
ponal
vinyl acetate (iarc)
vinyl acetate hq

Research Excerpts

Overview

Vinyl acetate is a synthetic organic ester that has been shown to produce nasal tumors in rats following exposure to 600 ppm in air. It is used to make polyvinyl acetate based polymers that are used in the manufacture of latex paints and adhesives.

ExcerptReferenceRelevance
"Vinyl acetate (VA) is a volatile compound and the main compound of the carpenter's glue. "( Respiratory functions and health risk assessment in inhalational exposure to vinyl acetate in the process of carpet manufacturing using Monte Carlo simulations.
Gruszecka-Kosowska, A; Khoshakhlagh, AH; Kumar, V; Saberi, HR, 2023
)
2.58
"Vinyl acetate monomer (VAM) is a site-of-contact carcinogen in rodents. "( Vinyl acetate monomer (VAM) genotoxicity profile: relevance for carcinogenicity.
Albertini, RJ, 2013
)
3.28
"Vinyl acetate is an example that is discussed extensively in this review."( Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
Bogdanffy, MS; Bolt, HM; Hengstler, JG; Oesch, F, 2003
)
1.27
"Vinyl acetate is a synthetic organic ester that has been shown to produce nasal tumors in rats following exposure to 600 ppm in air. "( Vinyl acetate decreases intracellular pH in rat nasal epithelial cells.
Bogdanffy, MS; Lantz, RC; Orozco, J, 2003
)
3.2
"Vinyl acetate (VA) is a commonly used chemical in polymerization and copolymerization processes and as a chemical intermediate. "( A two-generation reproduction study in rats receiving drinking water containing vinyl acetate.
Carpanini, FM; Cascieri, TC; Mebus, CA; Rickard, RW; Tyler, TR; Vinegar, MB, 1995
)
1.96
"Vinyl acetate is a nasal carcinogen in rats exposed by inhalation for 2 years to 200 and 600 ppm, but not 50 ppm."( Cytotoxicity and DNA-protein crosslink formation in rat nasal tissues exposed to vinyl acetate are carboxylesterase-mediated.
Bogdanffy, MS; Kuykendall, JR; Taylor, ML, 1993
)
1.23
"Vinyl acetate is a nasal carcinogen in rats, but not mice, and induces olfactory degeneration in both species."( A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity.
Andersen, ME; Bogdanffy, MS; Jarabek, A; Plowchalk, DR; Sarangapani, R, 1999
)
1.29
"Vinyl acetate is a nasal carcinogen in rats and induces olfactory degeneration in rats and mice."( Mode-of-action-based dosimeters for interspecies extrapolation of vinyl acetate inhalation risk.
Andersen, ME; Bogdanffy, MS; Plowchalk, DR; Sarangapani, R; Starr, TB, 2001
)
1.27
"Vinyl acetate is an ester that is used to make polyvinyl acetate based polymers that are used in the manufacture of latex paints and adhesives. "( Regional distribution and kinetics of vinyl acetate hydrolysis in the oral cavity of the rat and mouse.
Morris, JB; Sarangapani, R; Symanowicz, P, 2002
)
2.03

Effects

Vinyl acetate vapor has been shown to produce tumors of the nasal cavity in rats, but not mice.

ExcerptReferenceRelevance
"Vinyl acetate has been shown to induce nasal lesions in rodents in inhalation bioassays. "( Validation of human physiologically based pharmacokinetic model for vinyl acetate against human nasal dosimetry data.
Bloemen, LJ; Bogdanffy, MS; Corley, RA; Hinderliter, PM; Thrall, KD, 2005
)
2.01
"Vinyl acetate vapor has been shown to produce tumors of the nasal cavity in rats, but not mice, exposed by the inhalation route. "( Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate.
Bogdanffy, MS; Taylor, ML,
)
1.82

Actions

ExcerptReferenceRelevance
"Vinyl acetate was unable to cause formation of DPXLs in the absence of microsomes."( Reaction kinetics of DNA-histone crosslinking by vinyl acetate and acetaldehyde.
Bogdanffy, MS; Kuykendall, JR, 1992
)
1.26

Toxicity

ExcerptReferenceRelevance
"In view of divergent opinions concerning MAC value for vinyl acetate, a study on acute and chronic inhalatory toxic effect of this compound on animals was carried out."( [Experimental studies of acute and chronic toxic effects of vinyl acetate].
Bińkowski, J; Czajkowska, T; Górny, R; Knobloch, K; Kołakowski, J; Lao, I; Sokal, J; Stetkiewicz, J, 1986
)
0.76
" These results indicate that VA is not uniquely toxic to the conceptus."( Developmental toxicity of oral and inhaled vinyl acetate in the rat.
Cascieri, TC; Hurtt, ME; Rickard, RW; Tyler, TR; Vinegar, MB, 1995
)
0.55
" There were no adverse effects on survival in either species."( Chronic toxicity and oncogenicity inhalation study with vinyl acetate in the rat and mouse.
Beems, RB; Bogdanffy, MS; Cascieri, TC; Dreef-van der Meulen, HC; Feron, VJ; Rickard, RW; Tyler, TR; Vinegar, MB, 1994
)
0.53
" No adverse reactions were seen."( Development and implementation of a safety evaluation program for chemical fibers.
Bootman, J; Malinverno, G; Robatto, G, 1993
)
0.29
" This mode of action suggests that exposure levels that do not increase intracellular acidification beyond homeostatic bounds will be adequately protective of adverse downstream responses including cancer."( Differentiating between local cytotoxicity, mitogenesis, and genotoxicity in carcinogen risk assessments: the case of vinyl acetate.
Bogdanffy, MS; Valentine, R, 2003
)
0.53
" It is highly likely that critical, limiting steps in any given mechanistic pathway may become overwhelmed with increasing exposures, signaling the emergence of new modalities of toxic tissue injury at these higher doses."( Dose-dependent transitions in mechanisms of toxicity: case studies.
Andersen, ME; Bogdanffy, MS; Bus, JS; Cohen, SD; Conolly, RB; David, RM; Doerrer, NG; Dorman, DC; Gaylor, DW; Hattis, D; Rogers, JM; Setzer, RW; Slikker, W; Swenberg, JA; Wallace, K, 2004
)
0.32

Pharmacokinetics

Mathematical models have been developed to describe nasal epithelial tissue dosimetry with two compounds, vinyl acetate (VA) and methyl methacrylate (MMA), that cause toxicity in these tissues. These models couple computational fluid dynamics (CFD) calculations that map airflow patterns within the nose with physiologically based pharmacokinetic (PBPK) models.

ExcerptReferenceRelevance
"Mathematical models have been developed to describe nasal epithelial tissue dosimetry with two compounds, vinyl acetate (VA) and methyl methacrylate (MMA), that cause toxicity in these tissues These models couple computational fluid dynamics (CFD) calculations that map airflow patterns within the nose with physiologically based pharmacokinetic (PBPK) models that integrate diffusion, metabolism, and tissue interactions of these compounds."( Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate.
Andersen, ME; Bogdanffy, MS; Frederick, CB; Green, T, 2002
)
0.72
" A physiologically based pharmacokinetic (PBPK) model for vinyl acetate has been used in human risk assessment, but previous in vivo validation was conducted only in rats."( Validation of human physiologically based pharmacokinetic model for vinyl acetate against human nasal dosimetry data.
Bloemen, LJ; Bogdanffy, MS; Corley, RA; Hinderliter, PM; Thrall, KD, 2005
)
0.81

Bioavailability

ExcerptReferenceRelevance
" The bioavailability studies in healthy human volunteers indicated that the TTS of nimodipine, designed in the present study, provided steady-state plasma concentration of the drug with minimal fluctuations for 20 hr with improved bioavailability in comparison with the immediate release tablet dosage form."( Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
Bhaskar, P; Krishnaiah, YS; Satyanarayana, V,
)
0.13
" The resultant sandwich was heat-sealed to produce circle-shaped TTS (20 cm2) that were subjected to bioavailability study in human volunteers against immediate release nicorandil tablet."( Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers.
Al-Saidan, SM; Chandrasekhar, DV; Krishnaiah, YS; Satyanarayana, V, 2005
)
0.33
"It is well documented that the bioavailability of hydrophobic organic chemicals (HOCs) can vary substantially among sediments."( Characterization of polycyclic aromatic hydrocarbon bioavailability in estuarine sediments using thin-film extraction.
Birch, GE; Gobas, FA; Golding, CJ, 2007
)
0.34
" These nanodroplets, present as a dispersed phase, can potentially enhance oral bioavailability of poorly soluble drugs by serving as a drug reservoir that efficiently feeds the continuous aqueous solution phase following absorption of drug."( Origin of Nanodroplet Formation Upon Dissolution of an Amorphous Solid Dispersion: A Mechanistic Isotope Scrambling Study.
Gao, Y; Indulkar, AS; Mo, H; Raina, SA; Taylor, LS; Waters, JE; Zhang, GGZ, 2017
)
0.46
"Maintaining a supersaturated drug solution after the dissolution of the solid dispersions of water insoluble drugs continues to be a great challenge and is important to the oral bioavailability enhancement of hardly soluble drugs."( Tri-block polymer with interfacial layer formation ability and its use in maintaining supersaturated drug solution after dissolution of solid dispersions.
Fu, JJ; Liu, CC, 2018
)
0.48
"The tri-block polymer was not only able to stabilize the supersaturated drug solution of solid dispersions to enhance the oral bioavailability of hardly soluble drugs, but is also a potential candidate to construct micelles for systemic administration, due to the good compatibility and organic solvents free micelle formation procedure."( Tri-block polymer with interfacial layer formation ability and its use in maintaining supersaturated drug solution after dissolution of solid dispersions.
Fu, JJ; Liu, CC, 2018
)
0.48

Dosage Studied

The development of hepatic enzyme-altered foci (ATPase, GGTase) was investigated. Dose-response relationships for vinyl acetate-induced nonneoplastic and neoplastic responses are highly nonlinear, suggesting complex kinetic processes.

ExcerptRelevanceReference
"The development of hepatic enzyme-altered foci (ATPase, GGTase) was investigated after dosing vinyl acetate (200 and 400 mg/kg per day, orally) to newborn rats for 3 weeks, with or without subsequent promotion by phenobarbital."( Vinyl acetate, a structural analog of vinyl carbamate, fails to induce enzyme-altered foci in rat liver.
Bolt, HM; Laib, RJ, 1986
)
1.93
" Dose-response relationships for vinyl acetate-induced nonneoplastic and neoplastic responses are highly nonlinear, suggesting complex kinetic processes."( Mode-of-action-based dosimeters for interspecies extrapolation of vinyl acetate inhalation risk.
Andersen, ME; Bogdanffy, MS; Plowchalk, DR; Sarangapani, R; Starr, TB, 2001
)
0.83
" Coupled with exposure to metabolically formed acetaldehyde at high administered concentrations, nonlinear dose-response curves for epithelial tumors are produced."( Vinyl acetate-induced intracellular acidification: implications for risk assessment.
Bogdanffy, MS, 2002
)
1.76
" A linear dose-response relationship with no observable threshold seems to be a conservative but adequate description for the carcinogenic activity of many genotoxic carcinogens, such as aflatoxin B1, the tobacco-specific nitrosoketone NNK, and probably N,N-diethylnitrosamine."( Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
Bogdanffy, MS; Bolt, HM; Hengstler, JG; Oesch, F, 2003
)
0.55
" Regulatory hazard classification schemes and dose-response assessment paradigms generally require basic knowledge of genotoxic potential to guide decisions on which scheme or paradigm is most appropriate."( Differentiating between local cytotoxicity, mitogenesis, and genotoxicity in carcinogen risk assessments: the case of vinyl acetate.
Bogdanffy, MS; Valentine, R, 2003
)
0.53
" A lower confidence limit of a benchmark dose (BMDL10) of 477 mg/kg/d was obtained from a dose-response relationship between combined incidence of squamous cell carcinomas and papillomas in the oral cavity of mice and rats and the estimated daily VA intakes per body weight, and compared with literature values."( Carcinogenicity and chronic toxicity in mice and rats administered vinyl acetate monomer in drinking water.
Arito, H; Matsumoto, M; Matsushima, T; Nagano, K; Ohnishi, M; Umeda, Y; Yamamoto, S; Yamazaki, K, 2004
)
0.56
" The bioavailability studies in healthy human volunteers indicated that the TTS of nimodipine, designed in the present study, provided steady-state plasma concentration of the drug with minimal fluctuations for 20 hr with improved bioavailability in comparison with the immediate release tablet dosage form."( Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
Bhaskar, P; Krishnaiah, YS; Satyanarayana, V,
)
0.13
"Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full dose-response curve."( Dose-dependent transitions in mechanisms of toxicity: case studies.
Andersen, ME; Bogdanffy, MS; Bus, JS; Cohen, SD; Conolly, RB; David, RM; Doerrer, NG; Dorman, DC; Gaylor, DW; Hattis, D; Rogers, JM; Setzer, RW; Slikker, W; Swenberg, JA; Wallace, K, 2004
)
0.32
" Such a process has been proposed to have practical dose-response thresholds below which the intracellular environment can be maintained within homeostatic bounds and the contribution of exposure to carcinogenic risk is negligible."( Vinyl acetate induces intracellular acidification in mouse oral buccal epithelial cells.
Bogdanffy, MS; Melvin, JE; Nakamoto, T; Wagner, M, 2005
)
1.77
" Under these operating conditions, it is necessary to employ a suitable combined theoretical and experimental procedure able to detect the optimum process dosing time at both the laboratory and the industrial scale."( Emulsion polymerization of vinyl acetate: safe optimization of a hazardous complex process.
Copelli, S; Derudi, M; Lunghi, A; Pasturenzi, C; Rota, R; Sempere, J; Serra, E, 2011
)
0.67
" Solid dosage forms for longer term implantation require to be constructed from materials that will not degrade or erode over time and also offer the utmost biocompatibility and biostability."( The Production of Solid Dosage Forms from Non-Degradable Polymers.
Fuenmayor, E; Major, I; McConville, C, 2016
)
0.43
" Ni(II) ions initial concentration, pH, contact time and adsorbent dosage were optimized by response surface methodology (RSM) approach."( Nickel adsorption onto polyurethane ethylene and vinyl acetate sorbents.
Abbas, M; Ali, A; Ali, Z; Hussain, F; Iqbal, M; Nisar, J; Qamar, MA, 2017
)
0.71
"This work aimed to develop a new solid dosage formulation of vinpocetine (VPN) in the form of buccal freeze-dried pullulan-based tablets (lyoplant-tabs) loaded with physically modified drug binary system."( Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form.
Ahmed, TA, 2019
)
0.51
" Moreover, differential dose-response in terms of exogenous DNA adduct formation were observed between nasal respiratory and olfactory epithelium."( Molecular Dosimetry of DNA Adducts in Rats Exposed to Vinyl Acetate Monomer.
Fang, C; Hoffman, G; Hsiao, YC; Liu, CW; Lu, K, 2022
)
0.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency50.60020.000214.376460.0339AID720692
estrogen nuclear receptor alphaHomo sapiens (human)Potency56.31620.000229.305416,493.5996AID1259244
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.06310.001024.504861.6448AID588535
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency35.48130.001019.414170.9645AID588536
activating transcription factor 6Homo sapiens (human)Potency56.77440.143427.612159.8106AID1159516
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency66.82420.000627.21521,122.0200AID651741
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency56.31620.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency56.31620.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (287)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (11.85)18.7374
1990's31 (10.80)18.2507
2000's64 (22.30)29.6817
2010's113 (39.37)24.3611
2020's45 (15.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 97.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index97.32 (24.57)
Research Supply Index5.70 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index176.95 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (97.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.34%)5.53%
Reviews16 (5.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other281 (94.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]